Drug-Eluting Beat Bare Stents in Older Patients Undergoing PCI

This article originally appeared here.
Share this content:
Drug-Eluting Beat Bare Stents in Older Patients Undergoing PCI
Drug-Eluting Beat Bare Stents in Older Patients Undergoing PCI

TUESDAY, April 21, 2015 (HealthDay News) -- For older patients undergoing percutaneous coronary intervention (PCI), drug-eluting stents (DES) offer clinical benefit over bare metal stents (BMS), according to a study published in the May 1 issue of The American Journal of Cardiology.

Fabio Mangiacapra, M.D., Ph.D., from the Bio-Medico University of Rome, and colleagues examined the long-term efficacy and safety of DES in 635 consecutive elderly patients (≥75 years) who underwent PCI. One hundred seventy patients received at least one DES and 465 received BMS only. The researchers compared the incidence of net adverse clinical events (NACE) at a median follow-up of 31.2 months. Follow-up data were available for 593 patients.

The researchers found that at five years, the Kaplan-Meier estimate of NACE was significantly lower in the DES versus the BMS group (40.5 versus 55.7 percent). Benefit in the DES group was driven by significant reduction in myocardial infarction (8.6 versus 16.6 percent) and target vessel revascularization rates (7.9 versus 21.9 percent); there was no significant increase in the incidence of bleeding events (13.8 versus 12.2 percent; P = 0.882). Propensity score-adjusted Cox proportional hazard analysis confirmed these results.

"This net clinical benefit, resulting from persistent efficacy and safety over time, may support the use of DES as a reasonable option in patients ≥75 years," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

Congress Approves Bill Expanding Private Care for VA Patients

Congress Approves Bill Expanding Private Care for VA ...

New bill would open up access to private doctors for veterans

AAP Recommending Injectable Flu Shot for 2018-19 Flu Season

AAP Recommending Injectable Flu Shot for 2018-19 Flu ...

Children should receive injectable vaccine, which has been shown to be more consistently effective

Neurologists Identify New Type of Vertigo

Neurologists Identify New Type of Vertigo

Long-term prognosis favorable, with improvement of symptoms in more than half of patients